• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫内生长迟缓后的极端矮小身材:与追赶生长不足相关的因素

Extreme short stature after intrauterine growth retardation: factors associated with lack of catch-up growth.

作者信息

Edouard T, Trivin C, Lawson-Body E, Pinto G, Souberbielle J-C, Brauner R

机构信息

Université René-Descartes and Pediatric Endocrinology Unit, Fondation Hôpital Saint-Joseph, Paris, France.

出版信息

Horm Res. 2004;61(1):33-40. doi: 10.1159/000075195. Epub 2003 Nov 27.

DOI:10.1159/000075195
PMID:14646400
Abstract

UNLABELLED

The factors associated with lack of catch-up growth after intrauterine growth retardation (IUGR) are unknown.

OBJECTIVE

To identify these factors by analyzing the clinical features and growth hormone (GH)-insulin-like growth factor I (IGF-I) axis.

METHODS

95 patients with height <-3 SD after IUGR were assigned to group 1 without (n = 50) or group 2 with (n = 45) malformations. Twenty-one in group 1 and 19 in group 2 were treated with GH.

RESULTS

They were seen at 5.3 +/- 0.5 and 4 +/- 0.5 year (p = 0.02) with heights at -3.4 +/- 0.1 and -3.9 +/- 0.2 SD (p = 0.03). Group 1 differed from group 2 in having a lower frequency of consanguinity (2 vs. 28.9%, p < 0.001), and higher frequencies of target heights (26.5 vs. 6.7%, p = 0.02) and mothers' heights (34.7 vs. 8.9%, p < 0.01) <-2 SD, multiparity (26 vs. 8.9%, p < 0.05), prematurity (36 vs. 15.5%, p < 0.05) and cesarean section birth (42 vs. 17.8%, p = 0.01). The GH-IGF-I axis data and the height increases after 3 years of GH treatment (1.6 +/- 0.2 in group 1 and 1.1 +/- 0.3 SD in group 2) were similar.

CONCLUSION

The short height of the parents, particularly of the mother, is associated with factors limiting the catch-up growth after IUGR of children without malformations, while the high frequency of consanguinity in those with malformations suggests that transmitted fetal factors affect organogenesis or development.

摘要

未标注

宫内生长迟缓(IUGR)后缺乏追赶生长相关的因素尚不清楚。

目的

通过分析临床特征和生长激素(GH)-胰岛素样生长因子I(IGF-I)轴来确定这些因素。

方法

95例IUGR后身高<-3标准差的患者被分为1组(无畸形,n = 50)和2组(有畸形,n = 45)。1组21例和2组19例接受生长激素治疗。

结果

他们分别在5.3±0.5岁和4±0.5岁时就诊(p = 0.02),身高分别为-3.4±0.1和-3.9±0.2标准差(p = 0.03)。1组与2组的区别在于近亲结婚频率较低(2%对28.9%,p<0.001),而目标身高(26.5%对6.7%,p = 0.02)和母亲身高(34.7%对8.9%,p<0.01)<-2标准差、多产(26%对8.9%,p<0.05)、早产(36%对15.5%,p<0.05)及剖宫产出生(42%对17.8%,p = 0.01)的频率较高。生长激素-胰岛素样生长因子I轴的数据以及生长激素治疗3年后的身高增长(1组为1.6±0.2,2组为1.1±0.3标准差)相似。

结论

父母身材矮小,尤其是母亲身材矮小,与无畸形儿童IUGR后限制追赶生长的因素有关,而有畸形儿童中近亲结婚的高频率表明,传递的胎儿因素影响器官发生或发育。

相似文献

1
Extreme short stature after intrauterine growth retardation: factors associated with lack of catch-up growth.宫内生长迟缓后的极端矮小身材:与追赶生长不足相关的因素
Horm Res. 2004;61(1):33-40. doi: 10.1159/000075195. Epub 2003 Nov 27.
2
IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.在初始生长激素剂量逐步增加期间,胰岛素样生长因子-I(IGF-I)和胰岛素样生长因子结合蛋白-3(IGF binding protein-3)水平是生长激素缺乏儿童和小于胎龄儿出生的矮小儿童生长激素敏感性的指标。
Horm Res. 2005;64(2):68-76. doi: 10.1159/000087692. Epub 2005 Aug 19.
3
Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis?宫内生长迟缓儿童的生长、胰岛素样生长因子系统与皮质醇:追赶生长是否受下丘脑-垂体-肾上腺轴重编程的影响?
Pediatr Res. 2002 Jan;51(1):94-9. doi: 10.1203/00006450-200201000-00017.
4
[Infants born with development disorders. What about the long-term statural development? What are the therapeutic possibilities?].[患有发育障碍的新生儿。其长期身高发育情况如何?有哪些治疗可能性?]
Rev Med Brux. 1998 Dec;19(6):471-3.
5
[The effectiveness of recombinant growth hormone in height deficiency due to intrauterine growth retardation].
Med Clin (Barc). 1999 May 8;112(16):601-5.
6
Growth and growth hormone treatment in short stature children born small for gestational age.小于胎龄儿出生的身材矮小儿童的生长及生长激素治疗
Pediatr Endocrinol Rev. 2009 Feb;6 Suppl 3:350-7.
7
Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Study Group of IUGR.生长因子与宫内生长迟缓。II. 与正常对照受试者相比,宫内生长迟缓儿童的血清生长激素、胰岛素样生长因子(IGF)I及IGF结合蛋白3水平:从出生至两岁的前瞻性研究。宫内生长迟缓研究组
Pediatr Res. 1996 Jul;40(1):101-7. doi: 10.1203/00006450-199607000-00018.
8
Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.胰岛素样生长因子I与生长激素治疗第一年期间KIGS中特发性生长激素缺乏症、获得性生长激素缺乏症、特纳综合征和小于胎龄儿患者的生长反应。
Horm Res. 2009 Jan;71 Suppl 1:39-45. doi: 10.1159/000178036. Epub 2009 Jan 21.
9
GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.生长激素治疗及其对小于胎龄儿出生的矮小儿童骨密度、骨成熟和生长的影响:一项随机对照生长激素试验的3年结果
Clin Endocrinol (Oxf). 2003 Dec;59(6):779-87. doi: 10.1046/j.1365-2265.2003.01905.x.
10
Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
Growth Horm IGF Res. 2007 Jun;17(3):194-200. doi: 10.1016/j.ghir.2007.01.008. Epub 2007 Feb 26.

引用本文的文献

1
Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age.日本胎龄小的早产儿身材矮小的发生率和新生儿危险因素及生长激素治疗。
Sci Rep. 2019 Aug 22;9(1):12238. doi: 10.1038/s41598-019-48785-y.